Abeprazan Size:Contact [email protected] for quotation Smiles: CC1=CN([C@H]2CC[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O

Smiles: CC1=CN([C@H]2CC[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=O

Smiles: CN1C(=O)C=C(N(CC2=CC(F)=CC=C2C#N)C1=O)N1C[C@H](N)CCC1

HDACs/mTOR Inhibitor 1 is a dual Histone Deacetylases (HDACs) and mammalian target of Rapamycin (mTOR) target inhibitor for treating hematologic malignancies

2041071-54-7

Abeprazan Size:Contact [email protected] for quotation Smiles: CC1=CN([C@H]2CC[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O2)C(=O)NC1=OAbeprazan (DWP14012) is a potassium competitive acid blocker. Abeprazan inhibits H+, K+ ATPase by reversible potassium competitive ionic binding with no acid activation required. Abeprazan is developed as a potential alternative to proton pump inhibitor for the treatment of acid related diseases. Product information CAS Number: 1902954 60 2 Molecular Weight: 410. 41 Formula: C19H17F3N2O3S Chemical Name: {[5 (2,4 difluorophenyl) 1 (3